LRI Comments on NYT Article to Urge Advocacy for Lupus Research

Below is a Letter to the Editor that the LRI submitted in response to a recent article in The New York Times on the implications of private support for scientific research. Our goal is to help galvanize readers to respond with action by joining advocacy groups to urge Congress to allocate adequate budget for scientific discovery.

To the Editor:
Billionaires With Big Ideas Are Privatizing American Science,” by William J. Broad (Saturday, March 15), presents a thoughtful view of the implications of private support for scientific research. But he neglected the opportunity to galvanize readers to join advocacy groups in urging Congress to allocate adequate budget for scientific discovery.

For the U.S. to continue its leadership role in providing medical breakthroughs, funding biomedical research must be a priority.  If researchers cannot rely on consistent Congressional support, we jeopardize progress, stunt America’s global competitiveness, and lose a generation of young researchers.  

We at the Lupus Research Institute (LRI) advocate for a synergy of private and public spending. Founded by families and scientists impatient for progress, the LRI invests in pioneering basic research to find the cure of the autoimmune disease lupus by raising private sector funding. The LRI’s vetted, peer-reviewed investment allows investigators to initiate novel research and obtain highly competitive NIH funding to advance important new science.  

One sector cannot bear the burden alone. Each must complement the other to deliver vital scientific innovation.

Margaret Dowd
President and CEO
Lupus Research Institute
New York, March 17, 2014